Literature DB >> 3771565

Enzymes of vitamin B6 degradation. Purification and properties of 4- and 5-pyridoxolactonases.

Y J Jong, E E Snell.   

Abstract

4-Pyridoxolactone and 5-pyridoxolactone, formed by dehydrogenation of pyridoxal or isopyridoxal during the bacterial degradation of vitamin B6 by Pseudomonas MA-1 and Arthrobacter Cr-7, respectively, are hydrolyzed to the corresponding acids by distinct inducible lactonases which were purified to homogeneity. 4-Pyridoxolactonase from Pseudomonas MA-1 has an Mr of 54,000 and contains two probably identical subunits of Mr = 28,600. It has a pH optimum of 7.0, a Km of 5.9 microM, and a Vmax at 25 degrees C of 35.2 mumol X min-1 X mg-1. 5-Pyridoxolactonase from Arthrobacter Cr-7 has an Mr of 65,200 and also contains two probably identical subunits of Mr = 32,800. It has a pH optimum of 7.1-7.7, a Km of 300 microM, and a Vmax at 25 degrees C of 21.5 mumol-1 X min-1 X mg-1. The two lactonases require no added cofactors or metal ions; their activities are inhibited by sulfhydryl reagents but are not affected by metal-chelating reagents. Although the two lactonases are entirely specific for their respective substrates, 4-pyridoxolactone is a competitive inhibitor (KI = 52 microM) for 5-pyridoxolactonase, and 5-pyridoxolactone is a competitive inhibitor (KI = 48 microM) for 4-pyridoxolactonase.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3771565

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  2 in total

1.  Crystallization and preliminary X-ray analysis of 4-pyridoxolactonase from Mesorhizobium loti.

Authors:  Sayoko Matsuda; Nana Yokochi; Yu Yoshikane; Jun Kobayashi; Chu Nhat Huy; Seiki Baba; Seiki Kuramitsu; Bunzo Mikami; Toshiharu Yagi
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-08-22

2.  Structure of 4-pyridoxolactonase from Mesorhizobium loti.

Authors:  Jun Kobayashi; Yu Yoshikane; Toshiharu Yagi; Seiki Baba; Kimihiko Mizutani; Nobuyuki Takahashi; Bunzo Mikami
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-03-25       Impact factor: 1.056

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.